Abstract
There is a strong global tendency to find alternative ways to produce pharmaceutical active principles from biotechnology process. In this scenario, Brazil shows a small expression in both research and production. Worsening the situation, international suppliers of biopharmaceuticals to Brazil are losing interest in the market and discontinuing production, especially those related to onco-hematologic treatment. In this context, this project proposes the union of different scientific and technological skills to achieve a viable industrial process to biotechnologically produce L-asparaginase, a biopharmaceutical broadly used in the treatment of leukemia. This project will approach two main areas: optimization of endogenous and heterologous enzyme production, with bioprospecting groups of fungi from diverse biomes; and the protein rational engineering using L-asparaginase from Saccharomyces cerevisiae as scaffold for comparative studies with the bacterial isoforms currently employed in the therapy. Furthermore, crystallographic structures will be determined to guide the site-directed mutations, and random mutations produced by protein synthetic evolution will be evaluated. To improve stability, bioavailability, toxicity and allergenic aspects, many nanotechnology approaches, such as pegylation and nanoencapsulation in polimersomes, will be investigated. As a result, we expect this project can bring a national biopharmaceutical to the market. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
MÉTODO DE OBTENÇÃO DE L-ASPARAGINASE RECOMBINANTE DE BAIXA MASSA MOLAR, L-ASPARAGINASE RECOMBINANTE E USO DA MESMA BR 10 2016 024702 0 - Universidade de São Paulo (USP). ; Universidade Estadual Paulista Júlio de Mesquita Filho (Unesp) . Marcos Antonio De Oliveira; Gisele Monteiro De Souza; Adalberto Pessoa Junior; Leonardo Schultz Da Silva; Iris Munhoz Costa; Marcos Hiraki Toyama; Sandra Helena Poliselli Farsky - January 2016, 01
USO DE DITERPENOIDES ENT-CAURÂNOS EM ASSOCIAÇÃO A ANTIBIÓTICOS PARA INIBIÇÃO DE ENZIMAS PEROXIRREDOXINAS DE MICRORGANISMOS PARA O COMBATE DE INFECÇÕES MICROBIANAS BR 10 2020 016245 4 - Universidade de São Paulo (USP). ; Universidade Estadual Paulista Júlio de Mesquita Filho (Unesp) . Gisele Monteiro; Adalberto Pessoa Junior; Ana Júlia Fernandes Cardoso De Oliveira; Bruna Del Busso Zampieri; Carlos Abrunhosa Tairum Junior; Carlos Alexandre Breyer; Luis Eduardo Soares Netto; Marcos Antonio De Oliveira; Marcos Hikari Toyama; Melina Cardoso Dos Santos; Rolando Ié; Vanessa Da Costa Andrade - January 2020, 01